Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen K Lennerz

Showing results (11-20 of 234) with videos related to

Pageof 24
Sort By:
Der Pathologe|December 2, 2020
[Technical, operational, and regulatory considerations for the adoption of digital and computational pathology]Markus D Herrmann, Jochen K Lennerz
International Journal of Surgical Pathology|March 31, 2011
Ring around the rosesJochen K Lennerz, Andrew E Rosenberg
Life (Basel, Switzerland)|July 27, 2024
Technology and Future of Multi-Cancer Early DetectionDanny A Milner, Jochen K Lennerz
International Journal of Surgical Pathology|July 16, 2013
Amelanotic adenomaJochen K Lennerz, Gregory Y Lauwers
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 16, 2014
Jaundice in resected pancreatic cancer patientsFenja M Feld, Jochen K Lennerz
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 2, 2014
Comparison of MelanA/MART-1 and HMB45 labeling in desmoplastic melanomaStephanie E Weissinger, Jochen K Lennerz
European Journal of Epidemiology|February 15, 2024
Dimensions of health data IntegrityJochen K Lennerz, Nick Schneider, Karl Lauterbach
The Keio Journal of Medicine|October 8, 2011
Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraineKarl Messlinger, Michael J M Fischer, Jochen K Lennerz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2015
Basket Trials: Just the End of the First QuarterAlbrecht Stenzinger, Wilko Weichert, Jochen K Lennerz, et al.
The Oncologist|August 4, 2021
MET D1228N and D1246N are the Same Resistance Mutation in MET Exon 14 SkippingJonathan M Tsai, Aaron N Hata, Jochen K Lennerz
Pageof 24

Showing results (11-20 of 234) with videos related to

Sort By:
Pageof 24
Der Pathologe|December 2, 2020
[Technical, operational, and regulatory considerations for the adoption of digital and computational pathology]Markus D Herrmann, Jochen K Lennerz
International Journal of Surgical Pathology|March 31, 2011
Ring around the rosesJochen K Lennerz, Andrew E Rosenberg
Life (Basel, Switzerland)|July 27, 2024
Technology and Future of Multi-Cancer Early DetectionDanny A Milner, Jochen K Lennerz
International Journal of Surgical Pathology|July 16, 2013
Amelanotic adenomaJochen K Lennerz, Gregory Y Lauwers
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 16, 2014
Jaundice in resected pancreatic cancer patientsFenja M Feld, Jochen K Lennerz
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 2, 2014
Comparison of MelanA/MART-1 and HMB45 labeling in desmoplastic melanomaStephanie E Weissinger, Jochen K Lennerz
European Journal of Epidemiology|February 15, 2024
Dimensions of health data IntegrityJochen K Lennerz, Nick Schneider, Karl Lauterbach
The Keio Journal of Medicine|October 8, 2011
Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraineKarl Messlinger, Michael J M Fischer, Jochen K Lennerz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2015
Basket Trials: Just the End of the First QuarterAlbrecht Stenzinger, Wilko Weichert, Jochen K Lennerz, et al.
The Oncologist|August 4, 2021
MET D1228N and D1246N are the Same Resistance Mutation in MET Exon 14 SkippingJonathan M Tsai, Aaron N Hata, Jochen K Lennerz
Pageof 24